4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-279719
Director acquired 29,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Polsky Bruce Director | 2026-06-18 | Option exercise | +29,600 | 124,806 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Polsky Bruce Director | 2026-06-18 | Option exercise · Restricted Stock Units | −29,600 | 0 | D: show line 2 in the form | |||||
| Polsky Bruce Director | 2026-06-18 | Grant or award · Restricted Stock Units | +26,700 | 26,700 | D: show line 3 in the form | |||||
| Polsky Bruce Director | 2026-06-18 | Grant or award · Stock Option (Right to Buy) | +37,700 | 37,700 | D: show line 4 in the form |
Loading xslF345X06/ownership.xml…